» Articles » PMID: 35763279

Long COVID, Audiovestibular Symptoms and Persistent Chemosensory Dysfunction: a Systematic Review of the Current Evidence

Overview
Date 2022 Jun 28
PMID 35763279
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The persistence of auditory, vestibular, olfactory, and gustatory dysfunction for an extended time after COVID-19 has been documented, which represents an emerging challenge of which ENT specialists must be aware. This systematic review aims to evaluate the prevalence of persistent audiovestibolar and olfactory/gustatory symptoms in patients with "long-COVID".

Methods: The literature was systematically reviewed according to PRISMA guidelines; PubMed, Scopus and Google Scholar were screened by searching articles on audiovestibular symptoms and olfactory/gustatory dysfunction after SARS-CoV-2 infection. The keywords used were hearing loss, tinnitus, vertigo, smell disorders, parosmia, anosmia, hyposmia, dysgeusia combined with COVID-19 or SARS-CoV-2.

Results: 1100 articles were identified. After removal of duplicates (382), 702 articles were excluded, and 16 were included in the systematic review. All articles included identified an association between SARS-CoV-2 infection and persistent hearing or chemosensory impairment. The studies were published over a period of 2 years, between 2019 and 2021.

Conclusions: The likelihood of patients with persistent audiovestibular symptoms related to COVID-19 was different among the articles; however, olfactory and gustatory disturbances were more consistently reported. Studies with longer follow-up are required to fully evaluate the long-term impact of these conditions.

Citing Articles

Post COVID-19 and Long COVID Symptoms in Otorhinolaryngology-A Narrative Review.

Guntinas-Lichius O, Bitter T, Takes R, Lee V, Saba N, Makitie A J Clin Med. 2025; 14(2).

PMID: 39860512 PMC: 11765628. DOI: 10.3390/jcm14020506.


Persistent ENT Manifestations in Individuals who Recovered from COVID-19: A Systematic Review.

Sharma A, Jakhar R, Kakkar V, Singal G Int Arch Otorhinolaryngol. 2024; 28(4):e697-e701.

PMID: 39464351 PMC: 11511282. DOI: 10.1055/s-0043-1777805.


Long COVID, the Brain, Nerves, and Cognitive Function.

Reiss A, Greene C, Dayaramani C, Rauchman S, Stecker M, Leon J Neurol Int. 2023; 15(3):821-841.

PMID: 37489358 PMC: 10366776. DOI: 10.3390/neurolint15030052.


Alzheimer's early detection in post-acute COVID-19 syndrome: a systematic review and expert consensus on preclinical assessments.

Vandersteen C, Plonka A, Manera V, Sawchuk K, Lafontaine C, Galery K Front Aging Neurosci. 2023; 15:1206123.

PMID: 37416323 PMC: 10320294. DOI: 10.3389/fnagi.2023.1206123.


Late Complications of COVID-19; An Umbrella Review on Current Systematic Reviews.

SeyedAlinaghi S, Bagheri A, Razi A, Mojdeganlou P, Mojdeganlou H, Afsahi A Arch Acad Emerg Med. 2023; 11(1):e28.

PMID: 37215236 PMC: 10197916. DOI: 10.22037/aaem.v11i1.1907.


References
1.
Ibekwe T, Fasunla A, Orimadegun A . Systematic Review and Meta-analysis of Smell and Taste Disorders in COVID-19. OTO Open. 2020; 4(3):2473974X20957975. PMC: 7488903. DOI: 10.1177/2473974X20957975. View

2.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

3.
Stavem K, Ghanima W, Olsen M, Gilboe H, Einvik G . Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2020; 76(4):405-407. PMC: 7716295. DOI: 10.1136/thoraxjnl-2020-216377. View

4.
Boscolo-Rizzo P, Hummel T, Hopkins C, Dibattista M, Menini A, Spinato G . High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021; 59(6):517-527. DOI: 10.4193/Rhin21.249. View

5.
Lechien J, Chiesa-Estomba C, Beckers E, Mustin V, Ducarme M, Journe F . Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021; 290(2):451-461. DOI: 10.1111/joim.13209. View